AtriCure, Inc. (ATRC) Misses Q4 EPS by 10c, Offers Guidance
AtriCure, Inc. (NASDAQ: ATRC) reported Q4 EPS of ($0.24), $0.10 worse than the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
